Thomas A. MCCOURT - 20 May 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Tessler, Attorney-in-Fact
Issuer symbol: IRWD
Transactions as of: 20 May 2024
Net transactions value: -$436,136
Form type: 4
Filing time: 22 May 2024, 16:05:26 UTC
Previous filing: 12 Mar 2024
Next filing: 17 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	$436,136	-67,618	-5.6%	$6.45	1,150,330	20 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Content

The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.